Add to Calendar 3/27/2019 8:15:00 AM 3/28/2019 2:30:00 PM 2019 Annual Meeting: State of Possible Conference
This year’s Annual Meeting is now the State of Possible Conference where we'll celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facing the life sciences to ensure we can continue this incredible success. Attendees will hear from the brightest minds through keynotes, panel discussions and 15-minute Possible Talks, inspiring and engaging content in the style of a TED Talk. We'll also have a networking reception, the State of Possible Celebration, immediately following Day 1 of the conference, where we'll have great food, drinks, a DJ. Attendees will also have access to the exhibits at the Museum of Science. Join us as we celebrate the State of Possible!
 

If you haven’t attended our Annual Meeting before, it is the premier east coast life sciences conference and this year’s event is better than ever. With speakers like Katrine Bosley, John Maraganore, Jeremy Levin, George Church, and more, we have some of the brightest names in biotech talking about the issues impacting our industry. See our incredible lineup of speakers and topics below. Online registration closes at noon on Tuesday, March 26th. Walk-in registrations will be available on-site. 

 Royal Sonesta Boston, 40 Edwin Land Blvd Cambridge MA 02142
Partner, Health Advances, a PAREXEL Company
Sheela Hegde has 20 years of experience in advising senior executive teams on corporate strategy. Sheela co-leads Health Advances’ Biopharma Practice, helping companies maximize the value of their assets and build winning market positions. Sheela brings a cross-sector lens to providing strategic advice to her clients, which include the leading pharmaceutical and biotechnology companies as well as financial investors. Experienced in multiple therapeutic areas, Sheela has particular expertise in metabolic, CNS, and autoimmune fields. At Health Advances, Sheela heads the Metabolics, Autoimmune, and Drug Delivery sub-practices. Sheela joined Health Advances in 2005 with a background in corporate strategy and health care provider operations. Prior to Health Advances, Sheela worked at The Advisory Board where she managed client relationships and led research teams in areas related to hospital care delivery and new payment models. She also previously worked at Novartis Pharmaceuticals in the Cardiovascular Business Franchise and with the Japan affiliate. Sheela earned a BA in human biology with university distinction and Phi Beta Kappa from Stanford University, and an MBA from Harvard University.

Brought to you by